Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: An open-labeled pilot study

Tacrolimus is an effective option for induction treatment of SLE-diffuse proliferative glomerulonephritis. Further trials are necessary to determine the optimal dosage and duration of therapy, and its efficacy in comparison to standard regimens.